Dr. Pollard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3270Fax+1 617-632-4410
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2003 - 2006- University of WashingtonResidency, Pediatrics, 2000 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
MA State Medical License 2018 - 2024
ME State Medical License 2014 - 2018
WA State Medical License 2003 - 2016- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 44 citationsGemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AA...Jessica A. Pollard, Erin M. Guest, Todd A. Alonzo, Robert B. Gerbing, Mike R Loken
Journal of Clinical Oncology. 2021-05-28 - 8 citationsMezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, Daniela V Wenge, Florian Perner
Blood. 2024-04-11 - 16 citationsPegfilgrastim for prevention of chemotherapy-associated neutropenia in pediatric patients with solid tumors.Scott C. Borinstein, Jessica A. Pollard, Laura Winter, Douglas S. Hawkins
Pediatric Blood & Cancer. 2009-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
